遺傳指紋追蹤混紡棉纖維 | Applied DNA Sciences Launches Enhanced DNA Authentication Quantifying Cotton Species

遺傳指紋追蹤混紡棉纖維

Applied DNA Sciences（APDN）已經推出了能識別不同種類棉花的DNA認證技術- 這意味著消費品牌將能夠確定在其棉花裡面不適當的混紡織物的數量，不只是劣質混紡物的存在。

該公司表示：「在棉花定量裡為FibreTyping棉紡織品，使用一種強化的DNA認證技術，這是一項顯著的里程碑」。

該技術適用於優質超長纖維棉（ELS），該棉與短纖棉交織，並標註為100％Pima棉或100％埃及特長棉。

APDN 生命科學副總裁Michael Hogan博士表示：「簡單地說，它是關於誠實棉花。消費者希望從他們信得過的零售商和品牌購買產品。我們的品牌合作夥伴可以確信，他們採購自供應商的產品包含的是真材實料」。

「隨著我們DNA的定量檢測，將有助於保持棉花種植、遷移和與全球各地的消費者相連結，不僅在美國，而且在澳洲、巴西、中國大陸、埃及、印度、秘魯和土耳其」。

從歷史上看，像是埃及ELS棉或美國Pima棉的優質棉纖維，選擇加工者的目標是以最低價格買到最優質的棉花，透過利用不同品質和類型的纖維與棉交織，試圖能符合產品規格。

然而，當品牌尋找更高的邊際利潤且缺乏可用的高品質超長棉絨時，就產生了特級長纖維棉 (ELS)與非ELS短纖高地棉的交織。不同類型的纖維交織會導致產品不純，如以標記百分之百ELS棉出售，就違反美國和國際法律。

APDN補充道，披露纖維的含量，在紡織品及成衣貿易是不可或缺的；這對於製造商有職責知道，並正確地報告，在文件及產品標籤上標示纖維的含量。

APDN 紡織品銷售副總裁MeiLin Wan 表示：「這是一個關鍵的轉折點。提供定量的棉紗和布料是非常重要的，特別是胚布（灰色和米色）、紗線和布料」。

APDN 在過去的八年，一直致力於發展以DNA為基礎的供應鏈，防偽、防盜技術產品的基因定型和產品認證解決方案。

新聞來源：台灣紡拓會

【相關文章】
》日本帝人開發運動服用Octa Neo多層纖維 | Teijin Frontier develops Octa Neo multilayer fibre
》日本Omikenshi開發用陽光、人體遠紅外線發熱的纖維“Solar Touch”
》認識寶特瓶環保纖維 | What is recycled plastc bottle fiber?
》認識防火纖維 | What is Fire-retardant Fiber?

---

Applied DNA Sciences Launches Enhanced DNA Authentication Quantifying Cotton Species

STONY BROOK, NY--(Marketwired - April 05, 2016) - Applied DNA Sciences (ADNAS), Inc. (NASDAQ: APDN), a provider of DNA-based supply chain, anti-counterfeiting, anti-theft technology product genotyping and product authentication solutions, today is introducing proprietary enhanced DNA authentication technology specifically quantifying cotton species -- meaning that consumer cotton brands can now determine the amounts of inappropriate blends in their cotton, not just the presence of inferior blends. This is a significant milestone in cotton quantitation using an enhanced DNA authentication technology for fiberTyping® cotton textiles. This technology applies to premium extra long staple ("ELS") cottons that have been "blended" with shorter staple cotton, and labeled as 100% Pima, or 100% Egyptian ELS.

"Consumers unknowingly could buy a mislabeled product," said Dr. Michael E. Hogan, Ph.D., Vice President of Life Sciences at ADNAS. "They could be purchasing a sheet that says it is '100% Egyptian ELS' that is actually not 100% ELS, but, instead, made from yarn containing 30% ELS, and 70% Upland cotton. Our technology provides a method for clearly distinguishing the type of blending, especially in extra long staple cotton products."

During the past eight years, ADNAS' team of international molecular biologists, forensic scientists, quality control and assurance and technical advisors developed the scientific and commercial foundation for validating DNA tests for cotton. This was a significant investment including intellectual property, research, development, technical validation and forensic expertise.

"Simply put, it's about honest cotton," continued Hogan. "Consumers want to buy products from retailers and brands they trust. Our brand partners can be confident the products they source from suppliers contain truthful materials. With our quantitative DNA testing, we will help keep cotton growing, moving and connecting with consumers around the globe not only in the U.S., but also, in Australia, Brazil, China, Egypt, India, Peru and Turkey."

Historically, the goal of select processors of premium cotton fibers (e.g. Egyptian ELS or American Pima) was to buy the highest quality cotton at the lowest price, attempting to meet product specifications by blending bales with different fiber qualities and types. Blending of premium extra long staple cotton with shorter staple non-ELS upland cotton occurs when brands search for higher profit margins and there is a lack of available high quality extra long staple fiber. This blending of different fiber types results in impure products being labeled and sold as 100% ELS cotton, violating US and international laws.

"It has been reported that ELS cotton grown in Egypt is experiencing difficulties due to mixing of pure Egyptian ELS cotton seeds with poorer quality seeds," noted Hogan. "At recent global industry meetings, discussions were held on the standards for Egyptian cotton and the alleged fraudulent practices taking place now. Our fiberTyping testing enables proper diagnosis of these widely blended, counterfeited textiles."

Government agencies like the Federal Trade Commission established clear guidelines protecting the consumer by ensuring that products are based on accurate information on product origin, construction, quality, and care. The disclosure of fiber content is integral to trade in textiles and apparel; it is incumbent upon the manufacturer to know, and to correctly report, fiber content in both documentation and on product labels.

"This is a critical tipping point," said MeiLin Wan, Vice President of Textile Sales at ADNAS. "It is important to provide quantitative results for cotton yarns and fabrics, specifically for greige (gray and beige) yarn and fabric. Since they are unprocessed, the ability to extract DNA and precisely determine the quantity of ELS DNA, Upland DNA or a blend, is helpful to determine if the product is 100% pure. This is the tip of the iceberg; expect more technical innovations from Applied DNA in the coming year."

About Applied DNA Sciences

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. Our patented DNA-based solutions can be used to identify, tag, track, and trace products, to help assure authenticity, traceability and quality of products. SigNature® DNA describes the platform ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence, and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the polymerase chain reaction.

Go to adnas.com for more information, events and to learn more about how Applied DNA Sciences makes life real and safe. Common stock listed on NASDAQ under the symbol APDN, and warrants are listed under the symbol APDNW. 

Forward-Looking Statements

The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 14, 2015, and our subsequent quarterly report on Form 10-Q filed on February 10, 2016 which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

Original Article: Digital Journal